What happens if the Rb protein is mutated and cannot be phosphorylated?
Retinoblastoma protein Rb functions as central gatekeeper integrating mitogenic signaling with E2F transcription program controlling G1/S restriction point. In quiescent or early G1 cells, Rb exists in hypophosphorylated state, binding E2F1, E2F2, E2F3 through pocket domains A and B, simultaneously recruiting histone deacetylases, SWI/SNF chromatin remodelers, and Polycomb complexes to repress promoters of cyclin E, cyclin A, thymidine kinase, dihydrofolate reductase, and DNA polymerase subunits. Mitogens induce cyclin D-CDK4/6 synthesis downstream of Ras-MAPK and PI3K pathways, which initiates progressive phosphorylation of Rb at serine 780, 795, 807, 811. Subsequent cyclin E-CDK2 mediated hyperphosphorylation fully displaces Rb, liberating E2F to activate S-phase genes. Mutation eliminating CDK phosphorylation sites locks Rb in constantly bound conformation, maintaining E2F repression despite abundant cyclin-CDK activity. Consequently, cells fail to transcribe nucleotide biosynthesis enzymes and replication factors, arresting before S-phase commitment, illustrating how non-phosphorylatable Rb creates dominant negative barrier to proliferation. This circuitry is highly conserved across eukaryotes, integrating growth factor signals, DNA damage surveillance, and developmental cues, and its disruption frequently underlies oncogenesis, providing targets for checkpoint inhibitors and cancer therapeutics.
Ref: Weinberg, Biology of Cancer, 2nd ed., Chapter 8: Rb Pathway. NCBI Bookshelf: Cell Cycle Control.